Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- INS.LSE
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Instem PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Health Information Services
- Markedsværdi
- 19.96B
- Ent værdi
- 19.98B
- Pris/omsætning
- -
- Pris/bog
- 365.37
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- 21.01
- PEG
- -
- EPS-vekst
- 23.98%
- 1 års afkast
- 21.61%
- 3 års afkast
- 24.03%
- 5 års afkast
- 26.03%
- 10 års afkast
- 17.79%
Senest opdateret: 2024-12-17
UDBYTTE
INS.LSE betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | 23080.14 |
| Pris til FCF | 26869.88 |
| Pris til EBITDA | 5038.95 |
| EV i forhold til EBITDA | 5044.14 |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | - |
| Pris til egenkapital | 365.37 |
| EV i forhold til salg | - |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 24.05M |
| EPS (TTM) | - |
| FCF pr. aktie (TTM) | 0.03 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 0.00 |
| Bruttofortjeneste (TTM) | 0.00 |
| Driftsindkomst (TTM) | 0.00 |
| Nettoindkomst (TTM) | 0.00 |
| EPS (TTM) | - |
| EPS (1 år frem) | 39.50 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenstmargin (TTM) | - |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 8.44M |
| Nettotilgodehavender | 15.35M |
| Omsætningsaktiver i alt | 24.17M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 0.00 |
| Ejendomme, anlæg og udstyr | 1.45M |
| Sum aktiver | 83.65M |
| Kreditor | 4.59M |
| Kortfristet/nuværende langsigtet gæld | 2.05M |
| Summen af kortfristede forpligtelser | 25.50M |
| Sum gæld | 29.01M |
| Aktionærernes egenkapital | 54.64M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 865.00K |
| Investeringsudgifter (TTM) | 122.00K |
| Fri pengestrøm (TTM) | 743.00K |
| Udbetalt udbytte (TTM) | 0.00 |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | - |
| Afkast af aktiver | - |
| Afkast af investeret kapital | - |
| Kontant afkast af investeret kapital | 1.32% |
INFORMATION OM AKTIER
Nedsidepotensial
Loading...
Nedsidepotensial-data
| INS.LSE | S&P500 | |
| Nuværende prisfald fra top notering | -8.29% | -4.91% |
| Højeste prisfald | -66.08% | -56.47% |
| Højeste efterår dato | 27 Dec 2012 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -20.99% | -11.04% |
| Gennemsnitlig tid til nyt højdepunkt | 27 days | 12 days |
| Maks. tid til nyt højdepunkt | 1058 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
19.96B
Markedsværdi kategori
Large-cap
Beskrivelse
Instem plc, together with its subsidiaries, provides information technology solutions and services to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Blur Clinical Annonymization; Logbook ELN, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a windows-based system for non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; KnowledgeScan Target Safety Assessment services; SENDTrial, a web based solution that can be accessed through a subscription; and Predict delivers computational models. Further, the company provides Sorcerer Colony Counter; sales and administrative support; training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; software solutions to extract intelligence from research and development related healthcare data; and holds intellectual property rights and investment. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom. As of November 20, 2023, Instem plc was taken p
Personale
500
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
UK
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Ingen varer fundet